Results 171 to 180 of about 11,407 (242)

Migraine, monoclonal antibodies, and monitoring: a review of pharmacovigilance in the era of biologics. [PDF]

Front Pharmacol
Guarnieri L, Bosco F, Corasaniti MT, Citraro R, De Sarro G.   +4 more
europepmc   +1 more source

Non-signaling protein therapeutics: a mechanism-based regulatory framework to modernize biosimilar development and global harmonization. [PDF]

Front Med (Lausanne)
Niazi SK.
europepmc   +1 more source

Comparable remission and health care use in real-world inflammatory bowel disease patients initiating originator biologics <i>vs</i> biosimilars. [PDF]

World J Gastroenterol
Moura CS, Etingin A, Lukusa L, Singh H, Narula N, Targownik LE, Leung Y, Zezos P, Polewiczowska-Nowak B, Afif W, Bernatsky S.   +10 more
europepmc   +1 more source

Tocilizumab: From Bench to Bedside - A Comprehensive Review. [PDF]

Kans J Med
Khoury A, El Halabi L, Al Bayeh A, Katrib M, Nasr J, Reddy P.   +5 more
europepmc   +1 more source

Effectiveness and safety of adalimumab biosimilar in bio-naive patients with inflammatory bowel disease: a real-life multicenter observational study comparing ABP501, SB5, MSB11022, GP2017, and FKB327. [PDF]

Crohns Colitis 360
Regueiro C, Vázquez Rey MT, Bastón-Rey I, Galego MA, Campos AC, Baz López AM, Arriero GM, Ruiz Barcia MJ, Villaamil PV, EIGA.   +9 more
europepmc   +1 more source

Demonstrating interchangeability and biosimilarity for US biosimilars [PDF]

Generics and Biosimilars Initiative Journal, 2016
openaire   +1 more source

Biosimilars Development Conference Invitation

, 2015
The Biosimilars Group
core  

Regulatory Definitions and Classification of Biosimilar Medications Across the 6 Regions of the World Health Organization: A Scoping Review.

JAMA Health Forum
Watanabe JH, Strand MW, Walvekar M, Alfonso-Cristancho R.   +3 more
europepmc   +1 more source

Efficacy and safety of aflibercept biosimilars compared to aflibercept in the treatment of neovascular age-related macular degeneration: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Zhou Y, Zhan Z, Wang Z, Liu C.
europepmc   +1 more source

BIOSIMILARS IN ONCOLOGY – PART I: THE PRINCIPLES OF BIOSIMILARS

Belgian Journal of Medical Oncology, 2020
Moorkens, Evelien, Vandenplas, Yannick, barcina, Teresa, Barbier, Liese, Vulto, Arnold   +4 more
openaire   +2 more sources